Omeros Corporation (OMER)

Omeros Corporation (OMER) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -1.7%, 1 week +2.3%, 1 year +116.6%.

Omeros Corporation (OMER) is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class therapeutics targeting the complement system to treat immunologic disorders, rare diseases, and cancers.

Groups OMER belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Healthcare
• Life Sciences
• Rare Diseases
• Monoclonal Antibodies
• Immunotherapy
• Ophthalmology

OMER financial model: income statement, cash flow and balance sheet